Table 3.
Total doses administered in 2018-2019 (n, %) and percentage increase
| Vaccine | Doses admnistered in 2018-2019 (n, %) | Percentage increase |
| Flu | 102 | +164% |
| HAV* | 60 (24%) | +50% |
| HBV* | 56 (22.4%) | +33.3% |
| HPV9 | 66(26.4%) | (+3100%) |
| MenACWY | 46 (18.4%) | +46,5% |
| MenB | 46 (18.4%) | +46,5% |
| PCV13 | 68 (27.2%) | +66,6% |
| PPV23 | 68 (27.2%) | (+1600%) |
| Total | 250 | +370% |
* based on immunological status we administered HAV or HBV or HAV-HBV vaccine)